AP NEWS
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

AngioDynamics to Report Fiscal 2019 Third Quarter Financial Results on April 2, 2019

March 12, 2019

LATHAM, N.Y.--(BUSINESS WIRE)--Mar 12, 2019--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the third quarter of fiscal year 2019 before the market open on Tuesday, April 2, 2019. The Company’s management will host a conference call at 8:00 a.m. ET the same day to discuss the results.

To participate in the conference call, dial 1-877-407-0784 (domestic) or 1-201-689-8560 (international) and refer to the passcode 13688664.

This conference call will also be webcast and can be accessed from the “Investors” section of the AngioDynamics website at www.angiodynamics.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

A recording of the call will also be available from 11:00 a.m. ET on Tuesday, April 2, 2019, until 11:59 p.m. ET on Tuesday, April 9, 2019. To hear this recording, dial 1-844-512-2921 (domestic) or 1-412-317-6671 (international) and enter the passcode 13688664.

About AngioDynamics, Inc.

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products and venous products. For more information, visit  www.angiodynamics.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190312005585/en/

CONTACT: Investor Contact:

AngioDynamics, Inc.

Michael Greiner, Executive Vice President & CFO

(518) 795-1821

KEYWORD: UNITED STATES NORTH AMERICA NEW YORK

INDUSTRY KEYWORD: SURGERY HEALTH MEDICAL DEVICES ONCOLOGY

SOURCE: AngioDynamics, Inc.

Copyright Business Wire 2019.

PUB: 03/12/2019 04:01 PM/DISC: 03/12/2019 04:01 PM

http://www.businesswire.com/news/home/20190312005585/en